BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2006

View Archived Issues

Nostrum obtains rights to clot busting therapeutic protein from IMTECH

Read More

AstraZeneca gives lowdown on second quarter

Read More

Gardant updates acquisition and spin-off details

Read More

Pozen and AstraZeneca to develop esomeprazole/naproxen fixed dose combinations

Read More

Preterm birth prevention study of Prochieve completes enrollment

Read More

Phase II study of IR-103 in HIV patients cleared to add French sites

Read More

Oncaspar in combination with Gemzar begins phase I study

Read More

Enzon's IND approved for recombinant human mannose-binding lectin

Read More

Phase IIb study to assess PEP-005 Topical in actinic keratosis

Read More

Archemix and Nuvelo expand aptamer collaboration

Read More

CHDI and Edison team up to develop therapeutics for Huntington's disease

Read More

Satraplatin studied with Tarceva in phase II NSCLC trial

Read More

In vivo data show antiviral activity of AC-03-636

Read More

Phase IIb stroke study of DP-b99 completes enrollment

Read More

Alzheimer's candidate AZD-103 cleared for phase I study

Read More

BTA-798 for human rhinovirus advances through phase I testing

Read More

VAS-2870: novel NOX inhibitor for cardiovascular disease

Read More

Alemtuzumab to be tested in new phase II study for T-cell large granular lymphocytic leukemia

Read More

SAHA shows promise for the treatment of SMA

Read More

Positive phase I results of CI-1033 in combination with docetaxel in solid tumors reported

Read More

Novel antiviral agents reported in recent Shionogi patent

Read More

New analgesic agents reported in recent Schwarz patent

Read More

Recent patents cover novel BACE inhibitors for Alzheimer's disease

Read More

Recent patents describe new agents for anxiety, sleep disorders, etc.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing